Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 1-3 (KRTAP1-3) is a member of the keratin-associated protein (KAP) family, specifically classified among the high-sulfur KAPs[1][6]. These proteins contribute to the structural matrix of keratin intermediate filaments in hair fibers, interacting closely with hair keratins via extensive disulfide cross-linking, predominantly through cysteine residues. This association imparts rigidity and resilience to the hair shaft by forming a robust interfilamentous matrix[1][9]. KRTAP1-3 is located in a cluster of KAP genes at chromosome 17q12-q21[1][7], and its primary role is structural, being essential for proper hair fiber formation and properties. Although variants are associated with hair structure, KRTAP1-3 is not a receptor, enzyme, transporter, or other typical drug target, and there are no known drugs or therapeutic safety concerns related to this protein[1][2][7][9]. Choroid cancer is referenced as a disease association, but precise pathogenetic roles are unclear[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 1-3 (KRTAP1-3).